These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5038888)

  • 1. Striatonigral degeneration response to levodopa therapy.
    Rajput AH; Kazi KH; Rozdilsky B
    J Neurol Sci; 1972 Jul; 16(3):331-41. PubMed ID: 5038888
    [No Abstract]   [Full Text] [Related]  

  • 2. Striatonigral degeneration. Clinical-pathological correlations and response to stereotaxic surgery.
    Andrews JM; Terry RD; Spataro J
    Arch Neurol; 1970 Oct; 23(4):319-29. PubMed ID: 4920208
    [No Abstract]   [Full Text] [Related]  

  • 3. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
    Sharpe JA; Rewcastle NB; Lloyd KG; Hornykiewicz O; Hill M; Tasker RR
    J Neurol Sci; 1973 Jul; 19(3):275-86. PubMed ID: 4716845
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to levodopa therapy in striatonigral degeneration.
    Izumi K
    Lancet; 1972 Sep; 2(7779):707. PubMed ID: 4115837
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of late onset striatonigral degeneration.
    Przedborski S; Schiffmann SN; Monseu G; Maloteaux JM; Flament-Durand J
    Acta Neurol Belg; 1989; 89(1):29-37. PubMed ID: 2508411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Striato-nigral degeneration. Clinical and anatomic study of a case which responded favorably to L-Dopa].
    Feve JR; Mussini JM; Mathé JF; Cler JM; Nomballais MF
    Rev Neurol (Paris); 1977 Apr; 133(4):271-8. PubMed ID: 929031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?].
    Dell'Aria V; Ciannella L; Melone MA
    Acta Neurol Quad (Napoli); 1981; 42():212-5. PubMed ID: 7270052
    [No Abstract]   [Full Text] [Related]  

  • 8. Striatonigral degeneration. A clinicopathological study.
    Fearnley JM; Lees AJ
    Brain; 1990 Dec; 113 ( Pt 6)():1823-42. PubMed ID: 2276046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
    Bernheimer H; Birkmayer W; Hornykiewicz O; Jellinger K; Seitelberger F
    J Neurol Sci; 1973 Dec; 20(4):415-55. PubMed ID: 4272516
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rare extrapyramidal disorders: progressive supranuclear paralysis and striato-nigral degeneration].
    Marttila R; Kalimo H; Nikoskelainen E; Rinne UK
    Duodecim; 1982; 98(3):191-200. PubMed ID: 7060514
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome in striatonigral degeneration.
    Gibb WR
    Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance.
    Martin WR; Roberts TE; Ye FQ; Allen PS
    Can J Neurol Sci; 1998 Feb; 25(1):44-7. PubMed ID: 9532280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging.
    Lang AE; Curran T; Provias J; Bergeron C
    Can J Neurol Sci; 1994 Nov; 21(4):311-8. PubMed ID: 7533048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Striano-nigral degeneration].
    Mizuno Y
    Nihon Rinsho; 1978 May; Suppl():1720-1. PubMed ID: 691494
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
    Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa therapy in striatonigral degeneration.
    Weinmann RL
    Lancet; 1972 Oct; 2(7781):828. PubMed ID: 4116273
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterinosis of the basal ganglia associated with olivocerebellar atrophy in an adult.
    Neumann MA
    J Neuropathol Exp Neurol; 1971 Jul; 30(3):390-411. PubMed ID: 5567572
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients].
    Sigwald J; Chomette G; Raymondeaud C
    Sem Hop; 1972 Feb; 48(9):609-24. PubMed ID: 4339429
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case with degeneration of the thalamus, substantia nigra, pons and cerebellum as main symptoms--a contribution to the understanding of degeneration of the central nervous system].
    Oda M; Yamamoto T; Abe H; Shikiba S
    Shinkei Kenkyu No Shimpo; 1972 Jun; 16(3):514-20. PubMed ID: 5066193
    [No Abstract]   [Full Text] [Related]  

  • 20. Striatonigral degeneration disputed in familial disorder.
    Nielsen SL
    Neurology; 1977 Mar; 27(3):306. PubMed ID: 557771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.